[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@OncLive Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::43051682.png) @OncLive OncLive.com

OncLive.com posts on X about $abbv, $fro, files, adc the most. They currently have XXXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::43051682/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::43051682/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX +22%
- X Months XXXXXXX +3.20%
- X Year XXXXXXX -XX%

### Mentions: X [#](/creator/twitter::43051682/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::43051682/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX -XXXX%
- X Months XXX +7.50%
- X Year XXX -XX%

### Followers: XXXXXX [#](/creator/twitter::43051682/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::43051682/c:line/m:followers.svg)

- X Week XXXXXX +0.19%
- X Month XXXXXX +0.65%
- X Months XXXXXX +3.30%
- X Year XXXXXX +6%

### CreatorRank: undefined [#](/creator/twitter::43051682/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::43051682/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::43051682/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [currencies](/list/currencies)  XXXX%

**Social topic influence**
[$abbv](/topic/$abbv) 3.45%, [$fro](/topic/$fro) 3.45%, [files](/topic/files) 3.45%, [adc](/topic/adc) XXXX%

**Top accounts mentioned or mentioned by**
[@drchoueiri](/creator/undefined) [@myesmo](/creator/undefined) [@jonathanwlee23](/creator/undefined) [@ozdogan_md](/creator/undefined) [@weillcornell](/creator/undefined) [@amanchauhanmd](/creator/undefined) [@suyogcancer](/creator/undefined) [@g_mountzios](/creator/undefined) [@yekeduz_emre](/creator/undefined) [@mdmanishshah](/creator/undefined) [@tabernerojosep](/creator/undefined) [@tonymok9](/creator/undefined) [@christinelovly](/creator/undefined) [@andreanecchi](/creator/undefined) [@sanraffaelemi](/creator/undefined) [@profnadiah](/creator/undefined) [@maevelowery](/creator/undefined) [@drscotttagawa](/creator/undefined) [@jaydidelrivero](/creator/undefined) [@texasoncology](/creator/undefined)

**Top assets mentioned**
[AbbVie Inc (ABBV)](/topic/$abbv) [Frontline Ltd. (FRO)](/topic/$fro)
### Top Social Posts [#](/creator/twitter::43051682/posts)
---
Top posts by engagements in the last XX hours

"AbbVie Files BLA for First Hematologic ADC Pivekimab Sunirine In CADENZA pivekimab achieved a XX% cCR and XX% ORR in frontline BPDCN. Details here:"  
[X Link](https://x.com/OncLive/status/1980061399129673812) [@OncLive](/creator/x/OncLive) 2025-10-19T23:59Z 48.5K followers, XXX engagements


"ctDNA Clearance With Adjuvant Therapy Is Associated With Improved DFS in CRC @EmerikOsterlund @MDAndersonNews @myESMO #ESMO25"  
[X Link](https://x.com/OncLive/status/1982025589000159568) [@OncLive](/creator/x/OncLive) 2025-10-25T10:04Z 48.5K followers, XXX engagements